Lygenesis

About Lygenesis

LyGenesis is a clinical-stage biotechnology company focused on regenerative medicine by transforming a patient’s lymph nodes into bioreactors that grow functioning ectopic organs. Its allogeneic cell therapies aim to treat life-threatening diseases by enabling organ regeneration, notably for end-stage liver disease, through an outpatient endoscopic ultrasound procedure. The company highlights its pipeline across liver, thymus, kidneys, and pancreas indications and emphasizes reduced costs and risks relative to traditional organ transplantation.